TrinityJBivalacquaMDPhD
Urology • Philadelphia, PAMale Sexual Dysfunction, Surgical Oncology
Professor of Urology and Oncology, University of Pennsylvania, Abramson Cancer Center at Penn
Dr. Bivalacqua is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
# W
Philadelphia, PA 19104Phone+1 215-662-2891Fax+1 215-662-6734
Summary
- Dr. Trinity Bivalacqua is an urologist in Philadelphia, PA and is affiliated with Hospital of the University of Pennsylvania. He received his medical degree from Tulane University School of Medicine and has been in practice 13 years. He specializes in male sexual dysfunction and surgical oncology and is experienced in prostate cancer, urologic oncology, erectile dysfunction, bladder cancer, and penile cancer.
Education & Training
Johns Hopkins UniversityResidency, Urology, 2005 - 2010- Johns Hopkins University School of MedicineInternship, Transitional Year, 2004 - 2005
Tulane University School of MedicineClass of 2004
Certifications & Licensure
NJ State Medical License 2023 - 2025
PA State Medical License 2021 - 2024
MD State Medical License 2009 - 2022
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy Start of enrollment: 2017 Jul 01
- Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit Start of enrollment: 2010 Mar 01
- Improving Sensitivity of Urine Cytology for Bladder Cancer Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Residual cancer at radical cystectomy with or without neoadjuvant chemotherapy: a pathological stage-matched comparison.Leilei Xia, J Everett Knudsen, Daniel S Roberson, Erika L Wood, Anosh Dadabhoy
BJU International. 2025-01-01 - Comparison of Apixaban Versus Enoxaparin for Venous Thromboembolism Prevention After Radical Cystectomy: The CARE Trial.Katharine F Michel, Michelle Slinger, Hanna Stambakio, Ruchika Talwar, Amy N Luckenbough
European Urology Focus. 2024-10-22 - 1 citationsPathologic and survival outcomes following radical cystectomy for "progressive" and "de novo" muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant...Leilei Xia, Anosh Dadabhoy, Erika L Wood, Sejal V Mehta, Daniel S Roberson
Urologic Oncology. 2024-10-01
Journal Articles
- Original Contribution Targeted Sequencing of Plasmacytoid Urothelial Carcinoma Reveals Frequent TERT Promoter Mutations☆Morgan Cowan, Bert Vogelstein, Trinity J Bivalacqua, Gunes Guner, ScienceDirect
- Hospitalization and Readmission Costs After Radical Cystectomy in a Nationally Representative Sample: Does Urinary Reconstruction Matter?Hiten D Patel, Meera R Chappidi, Trinity J Bivalacqua, Gregory A Joice, Phillip M Pierorazio, Max Kates, Nikolai A Sopko, BJU International
Authored Content
- Intratunical Injection of Stromal Vascular Fraction Prevents Fibrosis in a Rat Model of Peyronie's DiseaseSeptember 2018
- Recommendations for Follow-up of Muscle-Invasive Bladder Cancer Patients: A Consensus by the International Bladder Cancer NetworkFebruary 2018
Press Mentions
‘Restorative’ Treatments for Erectile Dysfunction Aren’t Proven to Work. Men Pay Thousands AnywayNovember 30th, 2021- AUA, SMSNA Release New Acute Ischemic Priapism GuidelineSeptember 9th, 2021
- World NewsDecember 26th, 2020
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/trinity-bivalacqua
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
